These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7691891)

  • 21. An amino-terminal fragment of human lipopolysaccharide-binding protein retains lipid A binding but not CD14-stimulatory activity.
    Theofan G; Horwitz AH; Williams RE; Liu PS; Chan I; Birr C; Carroll SF; Mészáros K; Parent JB; Kasler H
    J Immunol; 1994 Apr; 152(7):3623-9. PubMed ID: 7511654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Function of lipopolysaccharide (LPS)-binding protein (LBP) and CD14, the receptor for LPS/LBP complexes: a short review.
    Schumann RR
    Res Immunol; 1992 Jan; 143(1):11-5. PubMed ID: 1373512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages.
    Kirikae F; Kirikae T; Qureshi N; Takayama K; Morrison DC; Nakano M
    Infect Immun; 1995 Feb; 63(2):486-97. PubMed ID: 7529746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipopolysaccharide modulation of a CD14-like molecule on porcine alveolar macrophages.
    Kielian TL; Ross CR; McVey DS; Chapes SK; Blecha F
    J Leukoc Biol; 1995 Apr; 57(4):581-6. PubMed ID: 7536786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bactericidal/permeability-increasing protein and lipopolysaccharide (LPS)-binding protein. LPS binding properties and effects on LPS-mediated cell activation.
    Wilde CG; Seilhamer JJ; McGrogan M; Ashton N; Snable JL; Lane JC; Leong SR; Thornton MB; Miller KL; Scott RW
    J Biol Chem; 1994 Jul; 269(26):17411-6. PubMed ID: 7517398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a biochemical lesion, and characteristic response to lipopolysaccharide (LPS) of a cultured macrophage-like cell mutant with defective LPS-binding.
    Nishijima M; Hara-Kuge S; Takasuka N; Akagawa K; Setouchi M; Matsuura K; Yamamoto S; Akamatsu Y
    J Biochem; 1994 Nov; 116(5):1082-7. PubMed ID: 7534758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Participation of lipopolysaccharide-binding protein in lipopolysaccharide-dependent macrophage activation.
    Tobias PS; Mathison J; Mintz D; Lee JD; Kravchenko V; Kato K; Pugin J; Ulevitch RJ
    Am J Respir Cell Mol Biol; 1992 Sep; 7(3):239-45. PubMed ID: 1381594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monocyte tissue factor induction by lipopolysaccharide (LPS): dependence on LPS-binding protein and CD14, and inhibition by a recombinant fragment of bactericidal/permeability-increasing protein.
    Mészáros K; Aberle S; Dedrick R; Machovich R; Horwitz A; Birr C; Theofan G; Parent JB
    Blood; 1994 May; 83(9):2516-25. PubMed ID: 7513203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor necrosis factor induction by an aqueous phenol-extracted lipopolysaccharide complex from Bacteroides species.
    Delahooke DM; Barclay GR; Poxton IR
    Infect Immun; 1995 Mar; 63(3):840-6. PubMed ID: 7532627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells.
    Nagaoka I; Hirota S; Niyonsaba F; Hirata M; Adachi Y; Tamura H; Heumann D
    J Immunol; 2001 Sep; 167(6):3329-38. PubMed ID: 11544322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neither CD14 nor serum is absolutely necessary for activation of mononuclear phagocytes by bacterial lipopolysaccharide.
    Lynn WA; Liu Y; Golenbock DT
    Infect Immun; 1993 Oct; 61(10):4452-61. PubMed ID: 7691750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipopolysaccharide (LPS)-binding protein and soluble CD14 function as accessory molecules for LPS-induced changes in endothelial barrier function, in vitro.
    Goldblum SE; Brann TW; Ding X; Pugin J; Tobias PS
    J Clin Invest; 1994 Feb; 93(2):692-702. PubMed ID: 7509346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipopolysaccharide stimulates HepG2 human hepatoma cells in the presence of lipopolysaccharide-binding protein via CD14.
    Nanbo A; Nishimura H; Muta T; Nagasawa S
    Eur J Biochem; 1999 Feb; 260(1):183-91. PubMed ID: 10091598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification and characterization of murine lipopolysaccharide-binding protein.
    Gallay P; Carrel S; Glauser MP; Barras C; Ulevitch RJ; Tobias PS; Baumgartner JD; Heumann D
    Infect Immun; 1993 Feb; 61(2):378-83. PubMed ID: 7678583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surfactant protein a inhibits lipopolysaccharide-induced immune cell activation by preventing the interaction of lipopolysaccharide with lipopolysaccharide-binding protein.
    Stamme C; Müller M; Hamann L; Gutsmann T; Seydel U
    Am J Respir Cell Mol Biol; 2002 Sep; 27(3):353-60. PubMed ID: 12204898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of lipopolysaccharide binding protein, CD14, and Toll-like receptors in the initiation of innate immune responses by Treponema glycolipids.
    Schröder NW; Opitz B; Lamping N; Michelsen KS; Zähringer U; Göbel UB; Schumann RR
    J Immunol; 2000 Sep; 165(5):2683-93. PubMed ID: 10946299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipopolysaccharide (LPS)-binding protein stimulates CD14-dependent Toll-like receptor 4 internalization and LPS-induced TBK1-IKKϵ-IRF3 axis activation.
    Tsukamoto H; Takeuchi S; Kubota K; Kobayashi Y; Kozakai S; Ukai I; Shichiku A; Okubo M; Numasaki M; Kanemitsu Y; Matsumoto Y; Nochi T; Watanabe K; Aso H; Tomioka Y
    J Biol Chem; 2018 Jun; 293(26):10186-10201. PubMed ID: 29760187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein.
    Wurfel MM; Hailman E; Wright SD
    J Exp Med; 1995 May; 181(5):1743-54. PubMed ID: 7536794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum factors, cell membrane CD14, and beta2 integrins are not required for activation of bovine macrophages by lipopolysaccharide.
    Jungi TW; Sager H; Adler H; Brcic M; Pfister H
    Infect Immun; 1997 Sep; 65(9):3577-84. PubMed ID: 9284122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes.
    Zweigner J; Gramm HJ; Singer OC; Wegscheider K; Schumann RR
    Blood; 2001 Dec; 98(13):3800-8. PubMed ID: 11739189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.